IncobotulinumtoxinA (Xeomin): background, mechanism of action, and manufacturing.
Aesthet Surg J
; 33(1 Suppl): 18S-22S, 2013 Mar.
Article
en En
| MEDLINE
| ID: mdl-23515195
ABSTRACT
IncobotulinumtoxinA is the third botulinum neurotoxin type A (BoNTA) to be approved for aesthetic use in the United States. This article introduces the new product with an overview of clinical applications and a discussion of the neurotoxin's molecular structure. The role and clinical relevance of complexing proteins in BoNTA products are discussed. Finally, incobotulinumtoxinA's mechanism of action is described.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Rejuvenecimiento
/
Neurotransmisores
/
Toxinas Botulínicas Tipo A
/
Cara
Límite:
Humans
Idioma:
En
Año:
2013
Tipo del documento:
Article